Canaccord Genuity Analysts Give Organigram (OGI) a C$5.50 Price Target

Canaccord Genuity set a C$5.50 price target on Organigram (CVE:OGI) in a research note released on Wednesday.

Shares of Organigram (OGI) opened at C$4.31 on Wednesday. Organigram has a 1-year low of C$1.95 and a 1-year high of C$5.68. The company has a market cap of $526.95, a price-to-earnings ratio of -39.18 and a beta of 8.35.

How to Become a New Pot Stock Millionaire

Organigram (CVE:OGI) last posted its quarterly earnings results on Monday, January 29th. The company reported C($0.01) EPS for the quarter, meeting the consensus estimate of C($0.01). The business had revenue of C$2.69 million during the quarter, compared to analysts’ expectations of C$2.86 million.

COPYRIGHT VIOLATION WARNING: “Canaccord Genuity Analysts Give Organigram (OGI) a C$5.50 Price Target” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://sportsperspectives.com/2018/03/10/canaccord-genuity-analysts-give-organigram-ogi-a-c5-50-price-target.html.

Organigram Company Profile

OrganiGram Holdings Inc, through its subsidiary, Organigram Inc, produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply